This publication is presented to you through Paradigm Publishing Services
Rutgers University Press
Chapter
Licensed
Unlicensed
Requires Authentication
ABOUT THE AUTHOR
You are currently not able to access this content.
You are currently not able to access this content.
Chapters in this book
- Frontmatter i
- CONTENTS vii
- FOREWORD ix
- INTRODUCTION 1
- 1. HARD WORK 10
- 2. THE ROCKEFELLER EFFECT 18
- 3. THE SHAPING OF A SCIENTIFIC MIND 25
- 4. THE ROCKEFELLER UNIVERSITY AND THE BROAD HORIZON 39
- 5. DIABETES 47
- 6. GLUCOSE, AGING, AND THE CROSS-LINKING OF BIOLOGY AND BUSINESS 56
- 7. THE CONCEPTUAL BREAKTHROUGH 71
- 8. CACHECTIN—TUMOR NECROSIS FACTOR 86
- 9. LEAVING THE ROCKEFELLER UNIVERSITY: The End of the Dream 101
- 10. PHILANTHROPY GOES AWRY 116
- 11. TRANSLATION IN TRANSITION 125
- 12. ANTI-TNF THERAPY Changing the Pharmaceutical Landscape 138
- 13. TAKING ON BIG PHARMA 144
- ACKNOWLEDGMENTS 163
- NOTES 165
- INDEX 191
- ABOUT THE AUTHOR 203
Chapters in this book
- Frontmatter i
- CONTENTS vii
- FOREWORD ix
- INTRODUCTION 1
- 1. HARD WORK 10
- 2. THE ROCKEFELLER EFFECT 18
- 3. THE SHAPING OF A SCIENTIFIC MIND 25
- 4. THE ROCKEFELLER UNIVERSITY AND THE BROAD HORIZON 39
- 5. DIABETES 47
- 6. GLUCOSE, AGING, AND THE CROSS-LINKING OF BIOLOGY AND BUSINESS 56
- 7. THE CONCEPTUAL BREAKTHROUGH 71
- 8. CACHECTIN—TUMOR NECROSIS FACTOR 86
- 9. LEAVING THE ROCKEFELLER UNIVERSITY: The End of the Dream 101
- 10. PHILANTHROPY GOES AWRY 116
- 11. TRANSLATION IN TRANSITION 125
- 12. ANTI-TNF THERAPY Changing the Pharmaceutical Landscape 138
- 13. TAKING ON BIG PHARMA 144
- ACKNOWLEDGMENTS 163
- NOTES 165
- INDEX 191
- ABOUT THE AUTHOR 203